Piper Sandler analyst Charles Neivert downgraded Celanese to Underweight from Neutral with a price target of $112, down from $120. The analyst believes many of the actions the company is undertaking to raise cash “will prove detrimental to future growth and earnings.” In addition, Celanese has a “significant number of obstacles to overcome” in the markets it participates in “simply to get back to a situation where revenue and earnings can grow again,” the analyst tells investors in a research note. Piper sees the situation in Europe created by an overflow of Chinese product as particularly challenging and says it may take another 12 months or more to reverse.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CE:
- DuPont’s Delrin Divestiture Could Deliver $1.8 Billion
- Buffett’s Berkshire Bet on Three U.S. Homebuilders in Q2
- Berkshire Hathaway takes new stake in D.R. Horton, exits McKesson position
- Celanese price target raised to $155 from $146 at Barclays
- Celanese price target raised to $145 from $128 at RBC Capital